Cytoglobin may be involved in the healing process of gastric mucosal injuries in the late phase without angiogenesis. |
2013 |
Dig Dis Sci. 2013 May;58(5):1198-206. |
Tanaka F, Tominaga K, Sasaki E, Sogawa M, Yamagami H, Tanigawa T, Shiba M, Watanabe K, Watanabe T, Fujiwara Y, Kawada N, Yoshizato K, Arakawa T. |
Risk factors for severe nonsteroidal anti-inflammatory drug-induced small intestinal damage. |
2013 |
Dig Liver Dis. 2013 May;45(5):390-5. |
Watanabe T, Tanigawa T, Nadatani Y, Nagami Y, Sugimori S, Okazaki H, Yamagami H, Watanabe K, Tominaga K, Fujiwara Y, Koike T, Arakawa T. |
Relation between bile acid reflux into the stomach and the risk of atrophic gastritis and intestinal metaplasia: A multicenter study of 2283 cases. |
2013 |
Dig Endosc.2013 Sep;25(5):519-25 |
Matsuhisa T, Arakawa T, Watanabe T, Tokutomi T, Sakurai K, Okamura S, Chono S, Kamada T, Sugiyama A, Fujimura Y, Matsuzawa K, Ito M, Yasuda M, Ota H, Haruma K. |
Endoscopic radial incision and cutting method for refractory esophageal stricture after endoscopic submucosal dissection of superficial esophageal carcinoma. |
2013 |
Dig Endosc. 2013 Mar;25(2):200-3 |
Minamino H, Machida H, Tominaga K, Sugimori S, Okazaki H, Tanigawa T, Yamagami H, Watanabe K, Watanabe T, Fujiwara Y, Arakawa T. |
Rebamipide inhibits indomethacin-induced small intestinal injury: Possible involvement of intestinal microbiota modulation by upregulation of α-defensin 5. |
2013 |
Eur J Pharmacol. 2013 Mar 15;704(1-3):64-9 |
Tanigawa T, Watanabe T, Otani K, Nadatani Y, Ohkawa F, Sogawa M, Yamagami H, Shiba M, Watanabe K, Tominaga K, Fujiwara Y, Takeuchi K, Arakawa T. |
Clinical Classification of Subgroups According to the Rome III Criteria Cannot be Used to Distinguish the Associated Respective Pathophysiology in Japanese Patients with Functional Dyspepsia. |
2013 |
Intern Med. 2013;52(12):1289-93. |
Ochi M, Tominaga K, Tanaka F, Tanigawa T, Yamagami H, Watanabe K, Watanabe T, Fujiwara Y, Arakawa T. |
Anti-tumour necrosis factor agents reduce non-steroidal anti-inflammatory drug-induced small bowel injury in rheumatoid arthritis patients. |
2013 |
Gut. 2014 Mar;63(3):409-14. |
Watanabe T, Tanigawa T, Shiba M, Nadatani Y, Nagami Y, Sugimori S, Yamagami H, Watanabe K, Tominaga K, Fujiwara Y, Koike T, Arakawa T. |
Incidence and risk factors of gastrointestinal bleeding in patients on low-dose aspirin therapy after percutaneous coronary intervention in Japan. |
2013 |
Scand J Gastroenterol. 2013 Mar;48(3):320-5 |
Nadatani Y, Watanabe T, Tanigawa T, Sogawa M, Yamagami H, Shiba M, Watanabe K, Tominaga K, Fujiwara Y, Yoshiyama M, Arakawa T. |
Sleep Disturbances and Refractory Gastroesophageal Reflux Disease Symptoms in Patients Receiving Once-Daily Proton Pump Inhibitors and Efficacy of Twice-Daily Rabeprazole Treatment. |
2013 |
Digestion. 2013 Sep 5;88(3):145-152 |
Fujiwara Y, Habu Y, Ashida K, Kusano M, Higuchi K, Arakawa T. |
Infliximab and/or immunomodulators inhibit immune responses to trivalent influenza vaccination in adults with inflammatory bowel disease. |
2013 |
J Crohns Colitis. 2013 Sep 4. pii: S1873-9946(13)00279-1. |
Hagihara Y, Ohfuji S, Watanabe K, Yamagami H, Fukushima W, Maeda K, Kamata N, Sogawa M, Shiba M, Tanigawa T, Tominaga K, Watanabe T, Fujiwara Y, Hirota Y, Arakawa T. |
High-Mobility Group Box 1 Inhibits Gastric Ulcer Healing through Toll-Like Receptor 4 and Receptor for Advanced Glycation End Products. |
2013 |
PLoS One. 2013 Nov 11;8(11):e80130. |
Nadatani Y, Watanabe T, Tanigawa T, Ohkawa F, Takeda S, Higashimori A, Sogawa M, Yamagami H, Shiba M, Watanabe K, Tominaga K, Fujiwara Y, Takeuchi K, Arakawa T. |
Mesenchymal stem cells administered in the early phase of tumorigenesis inhibit colorectal tumor development in rats. |
2013 |
J Clin Biochem Nutr. 2013 Nov;53(3):170-5. |
Katsuno T, Ochi M, Tominaga K, Tanaka F, Sogawa M, Tanigawa T, Yamagami H, Shiba M, Watanabe K, Watanabe T, Fujiwara Y, Arakawa T. |
Eosinophilic esophagitis-like endoscopic findings in patients with erosive esophagitis |
2013 |
Esophagus 2013;10:199-204 |
Fujiwara Y, Tanigawa T, Yamagami H, Watanabe K, Tominaga K, Watanabe T, Arakawa T. |
Role of small intestinal bacterial overgrowth in severe small intestinal damage in chronic non-steroidal anti-inflammatory drug users. |
2014 |
Scand J Gastroenterol. 2014 Mar;49(3):267-73. |
Muraki M, Fujiwara Y, Machida H, Okazaki H, Sogawa M, Yamagami H, Tanigawa T, Shiba M, Watanabe K, Tominaga K, Watanabe T, Arakawa T. |
A questionnaire-based survey on the diagnosis and management of inflammatory bowel disease in East asian countries in 2012. |
2014 |
Digestion. 2014;89(1):88-103. |
Hida N, Nakamura S, Hahm KB, Sollano JD, Zhu Q, Rani AA, Syam AF, Kachintorn U, Ueno F, Joh T, Naito Y, Suzuki H, Takahashi S, Fukudo S, Fujiwara Y, Kinoshita Y, Uchiyama K, Yamaguchi Y, Yoshida A, Arakawa T, Matsumoto T. |
Clinical efficacy of endoscopic submucosal dissection for adenocarcinoma of the esophagogastric junction |
2014 |
Endoscoy International Open. 2014; |
Nagami Y, Machida H, Shiba M, Obayashi T, Ominami M, Fukunaga S, Sugimori S, Tanigawa T, Yamagami H, Watanabe K, Watanabe T, Tominaga K, Fujiwara Y, Arakawa T. |
Randomised clinical trial: rabeprazole improves symptoms in patients with functional dyspepsia in Japan. |
2013 |
Aliment Pharmacol Ther. 2013 Oct;38(7):729-40 |
Iwakiri R, Tominaga K, Furuta K, Inamori M, Furuta T, Masuyama H, Kanke K, Nagahara A, Haruma K, Kinoshita Y, Higuchi K, Takahashi S, Kusano M, Iwakiri K, Kato M, Hongo M, Hiraishi H, Watanabe S, Miwa H, Naito Y, Fujimoto K, Arakawa T. |
A randomized, placebo-controlled, double-blind clinical trial of rikkunshito for patients with non-erosive reflux disease refractory to proton-pump inhibitor: the G-PRIDE study. |
2014 |
J Gastroenterol. 2014 Feb 18. [Epub ahead of print] |
Tominaga K, Kato M, Takeda H, Shimoyama Y, Umegaki E, Iwakiri R, Furuta K, Sakurai K, Odaka T, Kusunoki H, Nagahara A, Iwakiri K, Furuta T, Murakami K, Miwa H, Kinoshita Y, Haruma K, Takahashi S, Watanabe S, Higuchi K, Kusano M, Fujimoto K, Arakawa T; G-PRIDE Study Group. |
Covered self-expandable metal stents with an anti-migration system improve patency duration without increased complications compared with uncovered stents for distal biliary obstruction caused by pancreatic carcinoma: a randomized multicenter trial. |
2013 |
Am J Gastroenterol. 2013 Nov;108(11):1713-22. |
Kitano M, Yamashita Y, Tanaka K, Konishi H, Yazumi S, Nakai Y, Nishiyama O, Uehara H, Mitoro A, Sanuki T, Takaoka M, Koshitani T, Arisaka Y,?Shiba M, Hoki N, Sato H, Sasaki Y, Sato M, Hasegawa K, Kawabata H, Okabe Y, Mukai H. |
Use of capsule endoscopy in patients with Crohn's disease in Japan: a multicenter survey. |
2014 |
J Gastroenterol Hepatol. 2014;29:96-101 |
Esaki M, Matsumoto T, Watanabe K, Arakawa T, Naito Y, Matsuura M, Nakase H, Hibi T, Matsumoto T, Nouda S, Higuchi K, Ohmiya N, Goto H, Kurokawa S, Motoya S, Watanabe M.
|
Usefulness of non-magnifying narrow band imaging in screening of early esophageal squamous cell carcinoma: A prospective comparative study using propensity score matching |
2014 |
Am J Gastroenterol in press |
Nagami Y, Tominaga K, Machida H, Nakatani M, Kameda N, Sugimori S, Okazaki H, Tanigawa T, Yamagami H, Kubo N, Shiba M, Watanabe K,
Watanabe T, Iguchi H, Fujiwara Y, Ohira M, Hirakawa K, Arakawa T. |
(原著論文:和文) |
|
|
|
著書、学術論文等の名称 |
発表 |
発行所、発表雑誌等
または発表学会等の
名称、雑誌等の巻・頁 |
著者名 |
超音波内視鏡による内部低エコー領域所見と胃間葉系腫瘍の増大予測因子 |
2013 |
Progress in Medicine 33:436-44 |
大西 美穂, 富永 和作, 杉森 聖司, 山上 博一, 谷川 徹也, 渡辺 憲治, 渡辺 俊雄, 藤原 靖弘, 荒川 哲男 |
胃潰瘍治癒過程におけるアンチエイジング分子Klothoの発現動態と胃潰瘍治癒に及ぼす影響 |
2013 |
潰瘍 40巻 Page64-68 |
谷川 徹也, 渡辺 俊雄, 灘谷 祐二, 大谷 恒史, 十河 光栄, 山上 博一, 斯波 将次, 渡辺 憲治, 富永 和作, 藤原 靖弘, 荒川 哲男 |
当院における原因不明消化管出血症例の検討 |
2013 |
消化器内科56巻5号 Page517-523(2013.05) |
岡本純一,富永和作,杉森聖司,大林倫子,加藤邦洋,南野弘明,大南雅揮,灘谷裕二,中山佐容子,福永周生,永見康明,岡崎博俊,斯波将次,渡辺俊雄,藤原靖弘,荒川哲男 |
当院における潰瘍性大腸炎に対するインフリキシマブの臨床成績 |
2013 |
潰瘍40巻 Page44-46 |
野口 篤志, 渡辺 憲治, 谷川 徹也, 富永 和作, 渡辺 俊雄, 藤原 靖弘, 荒川 哲男 |
【PPI抵抗性胃食道逆流症の現状と治療戦略】 多チャンネル食道インピーダンス-pHモニタリングを用いたPPI抵抗性NERDの病態分類とbaseline impedanceの関連 |
2013 |
消化器内科57巻4号 422-425(2013.10) |
木幡 幸恵, 藤原 靖弘, 沢田 明也, 平本 慶子, 朴成華, 中原 憲一, 谷川 徹也, 山上 博一, 斯波 将次, 渡辺 憲治, 渡辺 俊雄, 富永 和作, 荒川 哲男 |